ABOS

Acumen Pharmaceuticals, Inc. Common Stock (ABOS) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.

ABOS has 1 Form 4 insider filing recorded at the SEC in the past 30 days^[1].